MX2008002065A - Derivados de pirazola como agentes terapeuticos. - Google Patents

Derivados de pirazola como agentes terapeuticos.

Info

Publication number
MX2008002065A
MX2008002065A MX2008002065A MX2008002065A MX2008002065A MX 2008002065 A MX2008002065 A MX 2008002065A MX 2008002065 A MX2008002065 A MX 2008002065A MX 2008002065 A MX2008002065 A MX 2008002065A MX 2008002065 A MX2008002065 A MX 2008002065A
Authority
MX
Mexico
Prior art keywords
therapeutic agents
pyrazole derivatives
diarylpyrazole
carboxamides
psychiatric
Prior art date
Application number
MX2008002065A
Other languages
English (en)
Spanish (es)
Inventor
Leifeng Cheng
Matti Ahlqvist
Robert Lundqvist
Henrik Sorensen
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MX2008002065A publication Critical patent/MX2008002065A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
MX2008002065A 2005-08-13 2006-08-09 Derivados de pirazola como agentes terapeuticos. MX2008002065A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0516661.6A GB0516661D0 (en) 2005-08-13 2005-08-13 Therapeutic agents
PCT/GB2006/002990 WO2007020388A1 (en) 2005-08-13 2006-08-09 Pyrazole derivatives as therapeutic agents

Publications (1)

Publication Number Publication Date
MX2008002065A true MX2008002065A (es) 2008-04-16

Family

ID=35098275

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008002065A MX2008002065A (es) 2005-08-13 2006-08-09 Derivados de pirazola como agentes terapeuticos.

Country Status (18)

Country Link
EP (1) EP1915364A1 (ja)
JP (1) JP2009504717A (ja)
KR (1) KR20080039939A (ja)
CN (1) CN101282963A (ja)
AR (1) AR055368A1 (ja)
AU (1) AU2006281300A1 (ja)
BR (1) BRPI0614626A2 (ja)
CA (1) CA2619228A1 (ja)
EC (1) ECSP088250A (ja)
GB (1) GB0516661D0 (ja)
IL (1) IL188759A0 (ja)
MX (1) MX2008002065A (ja)
NO (1) NO20080372L (ja)
RU (1) RU2008108179A (ja)
TW (1) TW200728300A (ja)
UY (1) UY29741A1 (ja)
WO (1) WO2007020388A1 (ja)
ZA (1) ZA200800698B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102009036604A1 (de) 2009-07-30 2011-02-03 Aicuris Gmbh & Co. Kg Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung
DE102011055815A1 (de) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
DE102012016908A1 (de) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
CN105061227A (zh) * 2015-07-27 2015-11-18 广东先强药业有限公司 一种环保的盐酸利托君生产方法
WO2020123855A1 (en) 2018-12-12 2020-06-18 University Of Washington Inhibitor compounds for male contraception

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05005742A (es) * 2002-12-02 2005-08-16 Astellas Pharma Inc Derivados de pirazol utiles como inhibidores de cox-i.
US7247628B2 (en) * 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
CA2555331C (en) * 2004-02-20 2011-01-04 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
TW200728300A (en) 2007-08-01
ECSP088250A (es) 2008-04-28
RU2008108179A (ru) 2009-09-20
AR055368A1 (es) 2007-08-22
CN101282963A (zh) 2008-10-08
WO2007020388A1 (en) 2007-02-22
EP1915364A1 (en) 2008-04-30
UY29741A1 (es) 2007-03-30
NO20080372L (no) 2008-04-16
AU2006281300A1 (en) 2007-02-22
GB0516661D0 (en) 2005-09-21
CA2619228A1 (en) 2007-02-22
ZA200800698B (en) 2009-01-28
KR20080039939A (ko) 2008-05-07
BRPI0614626A2 (pt) 2012-12-04
IL188759A0 (en) 2008-08-07
JP2009504717A (ja) 2009-02-05

Similar Documents

Publication Publication Date Title
TW200531689A (en) Therapeutic agents
TW200635903A (en) Therapeutic agents
TW200633986A (en) Therapeutic agents
TW200504034A (en) Therapeutic agents
TW200730525A (en) Therapeutic agents
MX2008002065A (es) Derivados de pirazola como agentes terapeuticos.
TW200801029A (en) Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
UA92503C2 (ru) Соединения 5-(фенилизоксазолилэтокси)-триазол-3-ил-замещенного пиридина для лечения неврологических, психиатрических или болевых расстройств
MY179527A (en) Catecholamine derivatives useful for the treatment of parkinson's disease
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
TW200635599A (en) Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
TW200745135A (en) Therapeutic agents
MXPA05013711A (es) Derivados 3-sustituidos de 5,6-diaril-pirazin-2-carboxi-amida y -2-sulfonamida, como moduladores de cb1.
WO2007038209A3 (en) Fused tetracyclic mglur1 antagonists as therapeutic agents
PL1951729T3 (pl) Pochodne pirymidyny połączone przez atom tlenu
JO2686B1 (en) Vehicles
TW200630374A (en) Thiazolyldihydroindazoles
TW200509933A (en) Therapeutic agents
TW200734324A (en) Therapeutic agents
MX2009004745A (es) Derivados de 1,2,3-triazol como inhibidores del receptor sigma.
PT1730147E (pt) Compostos de 1,4,8-triazaspiro[4.5]decan-2-ona substituídos para utilização no tratamento da obesidade
TW200639156A (en) New compounds
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
UY28839A1 (es) Agentes terapeuticos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal